Multiepitope Peptide Vaccination in Melanoma
This trial assesses the clinical efficacy of a multiepitope peptide vaccine with GM-CSF and KLH as immunological adjuvants in stage IV melanoma patients
Metastatic Melanoma
BIOLOGICAL: Tyrosinase, MAGE-3, GnTV
Clinical efficacy
Immune response|Safety
This trial assesses the clinical efficacy of a multiepitope peptide vaccine with GM-CSF and KLH as immunological adjuvants in stage IV melanoma patients